Description: Address issues in value-based contract accounting from an actuarial perspective. In Medicare and ACA business, what issues does risk adjustment present to value-based contract accounting? In Medicare, what issues do Part D present in value-based contract accounting and what are possible solutions? What are the issues in the use of provider stop loss in value-based contract accounting? Are there issues in the timeliness of claims in value-based contract accounting? Are we giving providers enough information for them to manage their population? How do we deal with deficit accounts? What are the pros and cons of capitation, gainshare, and full risk in value-based accounting?

Description: There exists profound health and access disparities among people from different demographics and socioeconomic backgrounds. Health equity is now a central policy directive for the U.S. government and CMS. Speakers representing policy, health care delivery and actuarial spaces will help you discover what health equity policy directions may look like, the challenges health care providers are facing and how actuaries can contribute to the effort in bridging the health equity divides.

Description: The health care sector in general, and physicians in particular, are a large and important part of the market for group and individual insurance products. Explore a variety of subjects related to physicians and disability insurance, including experience trends, purchasing trends, external factors affecting physicians, and the impact of the COVID-19 pandemic.

Description: This will be the most fun you'll ever have learning about applying health status based risk adjustment methodologies in the real world! Quantifying relative differences in the use of finite healthcare resources – due to differences in health status – isn't just fun, it's the very heart and soul of ASOP 45! Get ready for a rollercoaster of statistics, probability, and a few puns that might just make you laugh harder than a data outlier!

Description: This presentation seeks to educate SOA attendees on how Medicare provides care for HIV-positive members. HIV is a disease that has occupied a prominent place in the public's view since its initial discovery. Initially a terminal condition for the afflicted population, advances in anti-retroviral pharmaceutical therapies transformed HIV into a chronic condition in the 1990s.

Description: Underwriting smokers just got a lot more interesting. New research reveals that tobacco’s mortality is surprisingly durable and tenacious. Mortality is now shown to hover at 200% for years after a reported incidence of nicotine dependency, and smoking turns many common and manageable conditions into serious comorbidities with compounded mortality impact.

Description: Join a dynamic two-part panel, where we'll delve into organizational and personal innovation strategies, tactics, and success stories. Begin by uncovering how venture studios, payor/employer partnerships, and startup business units can propel your company's innovative edge.

Description: This session, which borrows heavily from SOA studies, US government data, and Munich Re’s global health data, will explore the blending of Covid deaths into the new baseline mortality.

Description: Take your professional development to the next level, all in one place. Join SOA Board President Dave Dillon and fellow leaders for an inside look at Professional Development Edge+ (PD Edge+), the Society of Actuaries’ comprehensive subscription for continuing education, created by actuaries, for actuaries. Now, in its second year, PD Edge+ is trusted by 88 corporate subscribers to meet their continuing education needs. This webcast is designed for both current subscribers and those exploring what PD Edge+ has to offer. During the session, you’ll see how PD Edge+ simplifies earning CE credits and staying current on industry trends. Don’t miss this opportunity to discover how PD Edge+ can make your learning more engaging, convenient, and impactful.

Description: Session 2A: Navigating Medicaid Single Preferred Drug Lists (PDLs) - A Deep Dive